These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Premalignant Clonal Hematopoietic Proliferations. Nardi V; Kuo FC; Hasserjian RP Am J Clin Pathol; 2019 Aug; 152(3):347-358. PubMed ID: 31305863 [TBL] [Abstract][Full Text] [Related]
6. Precursors to lymphoproliferative malignancies. Goldin LR; McMaster ML; Caporaso NE Cancer Epidemiol Biomarkers Prev; 2013 Apr; 22(4):533-9. PubMed ID: 23549397 [TBL] [Abstract][Full Text] [Related]
7. Screening for and diagnosis of monoclonal gammopathy. Chong YP; Lim SM; Loh TP; Mollee P; Wijeratne N; Choy KW J Clin Pathol; 2023 Nov; 76(11):727-733. PubMed ID: 37604683 [TBL] [Abstract][Full Text] [Related]
8. [Clonal evolution of early lymphoproliferations]. Fend F; Quintanilla-Martinez L Pathologe; 2018 Dec; 39(Suppl 2):247-249. PubMed ID: 30377786 [TBL] [Abstract][Full Text] [Related]
9. From MGUS to Multiple Myeloma, a Paradigm for Clonal Evolution of Premalignant Cells. van Nieuwenhuijzen N; Spaan I; Raymakers R; Peperzak V Cancer Res; 2018 May; 78(10):2449-2456. PubMed ID: 29703720 [TBL] [Abstract][Full Text] [Related]
10. Hospital population screening reveals overrepresentation of CD5(-) monoclonal B-cell lymphocytosis and monoclonal gammopathy of undetermined significance of IgM type. Voigtlaender M; Vogler B; Trepel M; Panse J; Jung R; Bokemeyer C; Bacher U; Binder M Ann Hematol; 2015 Sep; 94(9):1559-65. PubMed ID: 26040471 [TBL] [Abstract][Full Text] [Related]
11. Waldenström macroglobulinaemia and IgM monoclonal gammopathy of undetermined significance: emerging understanding of a potential precursor condition. McMaster ML; Caporaso N Br J Haematol; 2007 Dec; 139(5):663-71. PubMed ID: 18021080 [TBL] [Abstract][Full Text] [Related]
12. Molecular and biologic markers of progression in monoclonal gammopathy of undetermined significance to multiple myeloma. Mailankody S; Mena E; Yuan CM; Balakumaran A; Kuehl WM; Landgren O Leuk Lymphoma; 2010 Dec; 51(12):2159-70. PubMed ID: 20958231 [TBL] [Abstract][Full Text] [Related]
13. Overview of monoclonal gammopathies of undetermined significance. Vogt RF; Marti GE Br J Haematol; 2007 Dec; 139(5):687-9. PubMed ID: 18021082 [TBL] [Abstract][Full Text] [Related]
15. Familial monoclonal gammopathy of undetermined significance and multiple myeloma: epidemiology, risk factors, and biological characteristics. Greenberg AJ; Rajkumar SV; Vachon CM Blood; 2012 Jun; 119(23):5359-66. PubMed ID: 22354002 [TBL] [Abstract][Full Text] [Related]
16. Monoclonal Gammopathy of Undetermined Significance: A Comprehensive Review. Kaur J; Valisekka SS; Hameed M; Bandi PS; Varma S; Onwughalu CJ; Ibrahim H; Mongia H Clin Lymphoma Myeloma Leuk; 2023 May; 23(5):e195-e212. PubMed ID: 36966041 [TBL] [Abstract][Full Text] [Related]
17. The spectrum of somatic mutations in monoclonal gammopathy of undetermined significance indicates a less complex genomic landscape than that in multiple myeloma. Mikulasova A; Wardell CP; Murison A; Boyle EM; Jackson GH; Smetana J; Kufova Z; Pour L; Sandecka V; Almasi M; Vsianska P; Gregora E; Kuglik P; Hajek R; Davies FE; Morgan GJ; Walker BA Haematologica; 2017 Sep; 102(9):1617-1625. PubMed ID: 28550183 [TBL] [Abstract][Full Text] [Related]
18. Monoclonal Gammopathy of Undetermined Significance (MGUS)Monoclonal Gammopathy of Undetermined Significance (MGUS). Viera S; Ludek P; Zdeněk A; Marta K; Martin Š; Sabina Š; Zdeněk K Klin Onkol; 2018; 31(4):270-276. PubMed ID: 30541309 [TBL] [Abstract][Full Text] [Related]
19. Diagnosis, risk stratification and management of monoclonal gammopathy of undetermined significance and smoldering multiple myeloma. van de Donk NW; Mutis T; Poddighe PJ; Lokhorst HM; Zweegman S Int J Lab Hematol; 2016 May; 38 Suppl 1():110-22. PubMed ID: 27161311 [TBL] [Abstract][Full Text] [Related]